Internal Medicine, Rheumatology · Santa Clara, CA
NPI
1194189704
Since 2016
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
700 Lawrence Expy
Santa Clara, CA, 95051
Phone (408) 851-1000
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.0M
1,418 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Suresh Maharjan prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 325 prescriptions and refills. In total Suresh Maharjan wrote 1,418 Medicare prescriptions that cost $1.0M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-01.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Methotrexate Methotrexate Sodium | 325 | 870 | 116 | $6,300 |
| Prednisone Generic | 228 | 509 | 91 | $2,389 |
| Hydroxychloroquine Sulfate Generic | 149 | 456 | 56 | $4,962 |
| Leflunomide Generic | 117 | 334 | 43 | $3,453 |
| Rasuvo Methotrexate/Pf | 102 | 184 | 27 | $74K |
| Amjevita(Cf) Autoinjector Adalimumab-Atto | 47 | 59 | 11 | $53K |
| Enbrel Sureclick Etanercept | 44 | 47 | Under 11 | $247K |
| Sulfasalazine Generic | 43 | 118 | 19 | $2,308 |
| Allopurinol Generic | 39 | 122 | 14 | $343 |
| Enbrel Etanercept | 33 | 38 | Under 11 | $171K |
| Azathioprine Generic | 27 | 71 | Under 11 | $897 |
| Leucovorin Calcium Generic | 25 | 72 | 12 | $363 |
| Amjevita(Cf) Adalimumab-Atto | 22 | 32 | Under 11 | $36K |
| Mycophenolate Mofetil Generic | 21 | 56 | Under 11 | $4,180 |
| Xeljanz Tofacitinib Citrate | 15 | 18 | Under 11 | $45K |
Brand drugs: - claims; generic drugs: 1,026 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Suresh Maharjan were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.